Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00036790What this trial is testingMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more University of Wisconsin, Madison
Testing effectiveness (Phase 2)Ended earlyNCT03488251What this trial is testingPK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's LymphomaWho this might be right forNon-hodgkin Lymphoma,B CellRefractory Diffuse Large B-Cell LymphomaRelapsed Diffuse Large B-Cell Lymphoma Molecular Templates, Inc. 8
Early research (Phase 1)Looking for participantsNCT07052305What this trial is testingNT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell LymphomaWho this might be right forLarge B-cell Lymphoma Washington University School of Medicine 24
Testing effectiveness (Phase 2)Ended earlyNCT00295880What this trial is testingDonor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic CancerWho this might be right forMyeloproliferative DisordersLeukemiaLymphoma+1 more Masonic Cancer Center, University of Minnesota 12
Very early researchUnknownNCT05444322What this trial is testingRD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin LymphomaWho this might be right forMantle Cell LymphomaDiffuse Large B-cell LymphomaFollicular Lymphoma He Huang 18
Large-scale testing (Phase 3)Study completedNCT00265837What this trial is testingLaboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72
Not applicableEnded earlyNCT00952185What this trial is testingInfluenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy VolunteersWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more City of Hope Medical Center 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT05222555What this trial is testingSafety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL PatientsWho this might be right forDiffuse Large B Cell Lymphoma Incyte Corporation 53
Early research (Phase 1)Enrolling By InvitationNCT06827782What this trial is testingCord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System LymphomaWho this might be right forRefractory/Recurrent Central Nervous System Lymphoma Second Affiliated Hospital, Zhejiang University, School of Medicine 42
Not applicableStudy completedNCT00547196What this trial is testingAlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & DisordersWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes City of Hope Medical Center 10
Early research (Phase 1)Study completedNCT00002980What this trial is testingDecitabine in Treating Patients With Melanoma or Other Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more California Cancer Consortium
Early research (Phase 1)Study completedNCT02220842What this trial is testingA Safety and Pharmacology Study of Atezolizumab (MPDL3280A) Administered With Obinutuzumab or Tazemetostat in Participants With Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell LymphomaWho this might be right forLymphoma Hoffmann-La Roche 96
Testing effectiveness (Phase 2)Study completedNCT03349450What this trial is testingDPX-Survivac and Checkpoint Inhibitor in DLBCLWho this might be right forAdult Diffuse Large Cell LymphomaRecurrentAdult Refractory Diffuse Large B-Cell Lymphoma Sunnybrook Health Sciences Centre 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115What this trial is testingDonor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more City of Hope Medical Center 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT05658562What this trial is testingMT-2111 in Patients With Relapsed/Refractory DLBCLWho this might be right forDiffuse Large B-Cell Lymphoma Tanabe Pharma Corporation 46
Testing effectiveness (Phase 2)Study completedNCT03589469What this trial is testingStudy to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma RefractoryDiffuse Large B-cell Lymphoma Recurrent ADC Therapeutics S.A. 145
Early research (Phase 1)Looking for participantsNCT06026319What this trial is testingCD79b-19 CAR T Cells in Non-Hodgkin LymphomaWho this might be right forNon-hodgkin LymphomaRelapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma+7 more Marcela V. Maus, M.D.,Ph.D. 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07601607What this trial is testingLisaftoclax Plus Chidamide and Rituximab in Relapsed or Refractory Diffuse Large B-cell LymphomaWho this might be right forRelapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Sun Yat-sen University 51
Early research (Phase 1)Active Not RecruitingNCT05206357What this trial is testingStudy of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of EpcoritamabWho this might be right forNon-hodgkin Lymphoma Genmab 17